Evidence map›Paper›PMID 30208118›Full record

ArticlePloS one2018

Consideration of future consequences (CFC) serves as a buffer against aggression related to psychopathy.

Yongping Zhao, Jia Wei, Yuanshu Chen, Lingxiang Xia

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
1.3field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 6 citations in OpenAlex.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 3 institutions in 1 country.

Yongping ZhaoFaculty of Psychology, Southwest University, Chongqing, China.
Jia WeiSchool of Educational Science, Sichuan Normal University, Chengdu, Sichuan, China.
Yuanshu ChenSchool of Life Science and Technology, University Electronic Science and Technology, Chengdu, Sichuan, China.
Lingxiang XiaFaculty of Psychology, Southwest University, Chongqing, China.
Southwest University · CNSichuan Normal University · CNUniversity of Electronic Science and Technology of China · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Psychopathy is the most notorious trait in the Dark Triad, and it is strongly linked to many kinds of aggressive behaviors. However, not every individual who is characterized by psychopathy engages in aggression, which suggests that certain factors may attenuate the intensity of the relations between psychopathy and aggression. The purpose of the current study was to explore the protective roles of the consideration of future consequences (CFC) (high CFC-Future and low CFC- Immediate) in attenuating aggression related to psychopathy using proactive aggression (Study 1) and cyber-aggression (Study 2) behavior indexes. College students (Study 1; N = 1,058) and adults (Study 2; N = 350) voluntarily participated in this study. The results demonstrated that the relationship between psychopathy and aggressive behaviors was moderated by CFC-Future and CFC-Immediate. Individuals with high psychopathy scores who also had high CFC-Future scores or low CFC-Immediate scores exhibited less proactive aggression (Study 1) and left fewer aggressive online comments on news websites (Study 2). The results of the present study suggested that CFC serves as a buffer against aggression related to psychopathy and may extend the knowledge of the relationship between psychopathy and aggression.

Indexed as

AdolescentAdultAggressionFemaleHumansInternetLinear ModelsMaleMiddle AgedPersonalityPsychometricsSex FactorsSurveys and QuestionnairesYoung Adult

Identifiers

PMID30208118
PMCPMC6135489
OpenAlexW2889575181

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.